Clinical Trials Logo

Preleukemia clinical trials

View clinical trials related to Preleukemia.

Filter by:
  • Available  
  • Page 1

NCT ID: NCT05937568 Available - Clinical trials for Myelodysplastic Syndromes

Expanded Access for Treatment With Imetelstat

Start date: n/a
Phase:
Study type: Expanded Access

The objective of this expanded access protocol (EAP) is to provide access to treatment with imetelstat, the Investigational Product (IP), for eligible adult participants diagnosed with very low, low, intermediate risk (by Revised International Prognostic Scoring System, IPSS-R) myelodysplastic syndromes (MDS) who are red blood cell (RBC) transfusion-dependent, have failed to respond or have lost response or are ineligible for ESAs, had not received prior treatment with either a hypomethylating agent or lenalidomide and were non-del(5q), until such time that imetelstat becomes commercially available.

NCT ID: NCT05593185 Available - Clinical trials for Acute Myeloid Leukemia

Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS

Start date: n/a
Phase:
Study type: Expanded Access

Single patient expanded access program to provide galinpepimut-S for eligible patients with AML or MDS who have no other treatment option.